SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bronwyn S. Berthon, Lesley K. MacDonald-Wicks, Lisa G. Wood, A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans, Nutrition Research, 2014, 34, 3, 179

    CrossRef

  2. 2
    A. Tjokrowidjaja, B.S. Daniel, J.W. Frew, D.F. Sebaratnam, A.M. Hanna, S. Chee, A. Dermawan, C.Q. Wang, C. Lim, S.S. Venugopal, L.M. Rhodes, B. Welsh, T. Nijsten, D.F. Murrell, The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease, British Journal of Dermatology, 2013, 169, 5
  3. 3
    Axel Matzdorff, Ellis J. Neufeld, Jelena Roganovic, To Treat or Not To Treat—From Guidelines to Individualized Patient Management, Seminars in Hematology, 2013, 50, S12

    CrossRef

  4. 4
    James N. George, Consultative Hemostasis and Thrombosis, 2013,

    CrossRef

  5. 5
    James N. George, Children with ITP: Looking beyond the platelet count, Pediatric Blood & Cancer, 2012, 58, 3
  6. 6
    Kumi Nakazaki, Masataka Hosoi, Akira Hangaishi, Motoshi Ichikawa, Yasuhito Nannya, Mineo Kurokawa, Comparison between Pulsed High-Dose Dexamethasone and Daily Corticosteroid Therapy for Adult Primary Immune Thrombocytopenia: A Retrospective Study, Internal Medicine, 2012, 51, 8, 859

    CrossRef

  7. 7
    Deirdra R. Terrell, Laura A. Beebe, Barbara R. Neas, Sara K. Vesely, Jodi B. Segal, James N. George, Prevalence of primary immune thrombocytopenia in Oklahoma, American Journal of Hematology, 2012, 87, 9
  8. 8
    Henrik Frederiksen, Christian Fynbo Christiansen, Mette Nørgaard, Risk and prognosis of adult primary immune thrombocytopenia, Expert Review of Hematology, 2012, 5, 2, 219

    CrossRef

  9. You have free access to this content9
    James N. George, Sequence of treatments for adults with primary immune thrombocytopenia, American Journal of Hematology, 2012, 87, S1
  10. 10
    Julia L. Newton, Jessica A. Reese, Shirley I. Watson, Sara K. Vesely, Paula H. B. Bolton-Maggs, James N. George, Deirdra R. Terrell, Fatigue in adult patients with primary immune thrombocytopenia, European Journal of Haematology, 2011, 86, 5
  11. 11
    Zhenyu Li, Weiwei Mou, Guang Lu, Jiang Cao, Xupeng He, Xiuying Pan, Kailin Xu, Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia, International Journal of Hematology, 2011, 93, 1, 91

    CrossRef

  12. 12
    Paula H. B. Bolton-Maggs, Victoria S. L. Kok, Chronic immune thrombocytopenic purpura—who needs medication?, Annals of Hematology, 2010, 89, S1, 61

    CrossRef

  13. 13
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 2
  14. You have free access to this content14
    Ameet Sarpatwari, Shirley Watson, Sebhat Erqou, Howard Anderson, John Grainger, Julian P. T. Higgins, Adrian C. Newland, Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP), British Journal of Haematology, 2010, 151, 2
  15. 15
    James N. George, Management of Immune Thrombocytopenia — Something Old, Something New, New England Journal of Medicine, 2010, 363, 20, 1959

    CrossRef